SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-015114
Filing Date
2023-02-28
Accepted
2023-02-28 10:51:25
Documents
15
Period of Report
2023-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174406-8k_longeveron.htm   iXBRL 8-K 29319
2 AGREEMENT, DATED FEBRUARY 22, 2023 ea174406ex10-1_longeveron.htm EX-10.1 51312
3 PRESS RELEASE ea174406ex99-1_longeveron.htm EX-99.1 14550
4 GRAPHIC ex99-1_001.jpg GRAPHIC 7653
  Complete submission text file 0001213900-23-015114.txt   304893

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20230222.xsd EX-101.SCH 3233
6 XBRL LABEL FILE lgvn-20230222_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE lgvn-20230222_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT ea174406-8k_longeveron_htm.xml XML 3710
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 23680226
SIC: 2834 Pharmaceutical Preparations